Ha C - Search Results

1

Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis.

Ma S, Li R, Li G, Wei M, Li B, Li Y, Ha C. Ma S, et al. Among authors: ha c. Comput Biol Med. 2024 Aug;178:108747. doi: 10.1016/j.compbiomed.2024.108747. Epub 2024 Jun 18. Comput Biol Med. 2024. PMID: 38897150 Free article.

2

Laparoscopic Hysterectomy without Repositioning the Uterus to Treat Nonpuerperal Uterine Inversion: A Successful Case.

Wei M, Li YM, Guo H, Ma SH, Ha CF. Wei M, et al. J Minim Invasive Gynecol. 2021 Sep;28(9):1557-1558. doi: 10.1016/j.jmig.2021.04.005. Epub 2021 Apr 18. J Minim Invasive Gynecol. 2021. PMID: 33878491 No abstract available.

3

Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status.

Li Y, Nie Y, Guo H, Guo H, Ha C, Li Y. Li Y, et al. Among authors: ha c. Front Oncol. 2022 Mar 18;12:847085. doi: 10.3389/fonc.2022.847085. eCollection 2022. Front Oncol. 2022. PMID: 35372049 Free PMC article.

4

Value of the risk of ovarian malignancy algorithm index in predicting the recurrence of epithelial ovarian cancer.

Li R, Ma S, Zu Y, Wang F, Gao T, Yang Y, Guo H, Ha C. Li R, et al. Among authors: ha c. Biomark Med. 2022 Oct;16(14):1055-1066. doi: 10.2217/bmm-2022-0287. Epub 2022 Sep 5. Biomark Med. 2022. PMID: 36062577

5

The role of Connexin26 regulated by MiR-2114-3p in the pathogenesis of ovarian cancer.

Li Y, Wang L, Tian J, Zu Y, Wang F, Yang Y, Ma S, Cao J, Huang Q, Ha C. Li Y, et al. Among authors: ha c. Biochem Biophys Res Commun. 2023 Jan 15;640:105-116. doi: 10.1016/j.bbrc.2022.11.082. Epub 2022 Nov 28. Biochem Biophys Res Commun. 2023. PMID: 36565612 Free article.

6

U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-κB Pathway.

Wang F, Li YM, Li RY, Yang YE, Wei M, Ha C. Wang F, et al. Among authors: ha c. Womens Health Rep (New Rochelle). 2023 Feb 6;4(1):65-77. doi: 10.1089/whr.2021.0151. eCollection 2023. Womens Health Rep (New Rochelle). 2023. PMID: 36874235 Free PMC article.

7

Enhancing precision medicine: a nomogram for predicting platinum resistance in epithelial ovarian cancer.

Li R, Xiong Z, Ma Y, Li Y, Yang Y, Ma S, Ha C. Li R, et al. Among authors: ha c. World J Surg Oncol. 2024 Mar 21;22(1):81. doi: 10.1186/s12957-024-03359-9. World J Surg Oncol. 2024. PMID: 38509620 Free PMC article.

8

Overexpression of microRNA-205 predicts lymph node metastasis and indicates an unfavorable prognosis in endometrial cancer.

Ma YJ, Ha CF, Bai ZM, Li HN, Xiong Y, Jiang J. Ma YJ, et al. Oncol Lett. 2016 Dec;12(6):4403-4410. doi: 10.3892/ol.2016.5262. Epub 2016 Oct 14. Oncol Lett. 2016. PMID: 28105153 Free PMC article.

9

Differential Expression and Bioinformatics Analysis of tRF/tiRNA in Endometriosis Patients.

Li WS, Li YL, Cao R, Ha CF, Sun S, Yu L, Li J. Li WS, et al. Biomed Res Int. 2022 Mar 3;2022:9911472. doi: 10.1155/2022/9911472. eCollection 2022. Biomed Res Int. 2022. PMID: 35281615 Free PMC article.

10

Development of a Genomic Signatures-Based Predictor of Initial Platinum-Resistance in Advanced High-Grade Serous Ovarian Cancer Patients.

Li Y, Zhang X, Gao Y, Shang C, Yu B, Wang T, Su J, Huang C, Wu Y, Guo H, Ha C. Li Y, et al. Among authors: ha c. Front Oncol. 2021 Mar 5;10:625866. doi: 10.3389/fonc.2020.625866. eCollection 2020. Front Oncol. 2021. PMID: 33747898 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,292 results

Search Page

Filters